{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T06:51:37Z","timestamp":1772779897438,"version":"3.50.1"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,1,7]],"date-time":"2016-01-07T00:00:00Z","timestamp":1452124800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100010679","name":"Pasteur Institute of Iran","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100010679","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["DARU J Pharm Sci"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s40199-015-0139-0","type":"journal-article","created":{"date-parts":[[2016,1,6]],"date-time":"2016-01-06T20:24:17Z","timestamp":1452111857000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Two COX-2 inhibitors induce apoptosis in human erythroleukemia K562cells by modulating NF-\u03baB and FHC pathways"],"prefix":"10.1186","volume":"24","author":[{"given":"Shaghayegh","family":"Norouzi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahnaz","family":"Norouzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohsen","family":"Amini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amir","family":"Amanzadeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamad","family":"Nabiuni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saeed","family":"Irian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mona","family":"Salimi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,1,7]]},"reference":[{"key":"139_CR1","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.fitote.2011.11.012","volume":"83","author":"P Anjali","year":"2012","unstructured":"Anjali P, Faraha S, Amit KS. Synthetic and green vegetable isothiocyanates target red blood leukemia cancers. Fitoterapia. 2012;83:255\u201365.","journal-title":"Fitoterapia"},{"key":"139_CR2","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.canlet.2011.11.029","volume":"317","author":"S Shi","year":"2012","unstructured":"Shi S, Yao W, Xu J, Long J, Liu C, Yu X. Combinational therapy: New hope for pancreatic cancer. Cancer Lett. 2012;317:127\u201335.","journal-title":"Cancer Lett"},{"key":"139_CR3","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1158\/1535-7163.MCT-05-0213","volume":"4","author":"Y Moon","year":"2005","unstructured":"Moon Y, Jr Bottone FG, McEntee MF, Eling TE. Suppression of tumor cell invasion by cyclooxygenase inhibitors is mediated by thrombospondin-1 via the early growth response gene Egr-1. Mol Cancer Ther. 2005;4:1551\u20138.","journal-title":"Mol Cancer Ther"},{"key":"139_CR4","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1007\/s002800051007","volume":"45","author":"CT Hsueh","year":"2000","unstructured":"Hsueh CT, Chiu CF, Kelsen DP, Schwartz GK. Selective inhibition of cyclooxygenase-2 enhances mitomycin-C-induced apoptosis. Cancer Chemother Pharmacol. 2000;45:389\u201396.","journal-title":"Cancer Chemother Pharmacol"},{"key":"139_CR5","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1002\/ajh.20542","volume":"81","author":"GS Zhang","year":"2006","unstructured":"Zhang GS, Liu DS, Dai CW, Li RJ. Antitumor effects of celecoxib on K562 leukemia cells are mediated by cell-cycle arrest, caspase-3 activation, and downregulation of Cox-2 expression and are synergistic with hydroxyureaor imatinib. Am J Hematol. 2006;81:242\u201355.","journal-title":"Am J Hematol"},{"key":"139_CR6","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1016\/j.bcp.2003.11.004","volume":"67","author":"JL Wang","year":"2004","unstructured":"Wang JL, Lin KL, Chen JS, Lu YC, Jiann BP, Chang HT, et al. Effect of celecoxib on Ca2+ movement and cell proliferation in human osteoblasts. Biochem Pharmacol. 2004;67:1123\u201330.","journal-title":"Biochem Pharmacol"},{"key":"139_CR7","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/j.bcp.2007.08.029","volume":"75","author":"P Pyrko","year":"2008","unstructured":"Pyrko P, Kardosh A, Sch\u00f6nthal AH. Celecoxib transiently inhibits cellular protein synthesis. Biochem Pharmacol. 2008;75:395\u2013404.","journal-title":"Biochem Pharmacol"},{"key":"139_CR8","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.canlet.2004.11.002","volume":"224","author":"J Subhashini","year":"2005","unstructured":"Subhashini J, Mahipal SV, Reddanna P. Anti proliferative and apoptotic effects of celecoxib on human chronic myeloid leukemia in vitro. Cancer Lett. 2005;224:31\u201343.","journal-title":"Cancer Lett"},{"key":"139_CR9","first-page":"495","volume":"26","author":"H Du","year":"2011","unstructured":"Du H, Li W, Wang Y, Chen S, Zhang Y. Celecoxib induces cell apoptosis coupled with upregulation of the expression of VEGF by a mechanism involving ER stress in human colorectal cancer cells. Oncol Rep. 2011;26:495\u2013502.","journal-title":"Oncol Rep"},{"key":"139_CR10","doi-asserted-by":"publisher","first-page":"1769","DOI":"10.1093\/jnci\/djh322","volume":"96","author":"X Liu","year":"2004","unstructured":"Liu X, Yue P, Zhou Z, Khuri FR, Sun SY. Death receptor regulation and celecoxib-induced apoptosis in human lung cancer cells. J Natl Cancer Inst. 2004;96:1769\u201380.","journal-title":"J Natl Cancer Inst"},{"key":"139_CR11","doi-asserted-by":"publisher","first-page":"4253","DOI":"10.1007\/s00044-012-0436-9","volume":"22","author":"P Miralinaghi","year":"2013","unstructured":"Miralinaghi P, Salimi M, Amirhamzeh A, Norouzi M, MostafapourKandelousi H, Shafiee A, et al. Synthesis, molecular docking study, and anticancer activity of triaryl-1,2,4-oxadiazole. Med Chem Res. 2013;22:4253\u201362.","journal-title":"Med Chem Res"},{"key":"139_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/(SICI)1097-0320(19980101)31:1<1::AID-CYTO1>3.0.CO;2-R","volume":"31","author":"M Engeland Van","year":"1998","unstructured":"Van Engeland M, Nieland LJ, Ramaekers FC, Schutte B, Reutelingsperger CP. AnnexinV affinity assay: a review on an apoptosis detection system based on phosphatidylserine exposure. Cytometry. 1998;31:1\u20139.","journal-title":"Cytometry"},{"key":"139_CR13","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1161\/01.CIR.88.3.1190","volume":"88","author":"Y Shi","year":"1993","unstructured":"Shi Y, Hutchinson HG, Hall DJ, Zalewski A. Downregulation of c-myc expression by antisense oligonucleotides inhibits proliferation of human smooth muscle cells. Circulation. 1993;88:1190\u20135.","journal-title":"Circulation"},{"key":"139_CR14","first-page":"1","volume":"7","author":"Y Sun","year":"2012","unstructured":"Sun Y, Li Y, Luo D, Liao DJ. Pseudogenes as weaknesses of ACTB (Actb) and GAPDH (Gapdh) used as reference genes in reverse transcription and polymerase chain reactions. PLoS One. 2012;7:1\u201311.","journal-title":"PLoS One"},{"key":"139_CR15","doi-asserted-by":"publisher","first-page":"4843","DOI":"10.1242\/jcs.00151","volume":"115","author":"C Fan","year":"2002","unstructured":"Fan C, Yang J, Engelhardt JF. Temporal pattern of NFkappaB activation influences apoptotic cell fate in a stimuli-dependent fashion. J Cell Sci. 2002;115:4843\u201353.","journal-title":"J Cell Sci"},{"key":"139_CR16","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.canlet.2012.09.008","volume":"328","author":"R Benelli","year":"2013","unstructured":"Benelli R, Ven\u00e8 R, Minghelli S, Carlone S, Gatteschi B, Ferrari N. Celecoxib induces proliferation and Amphiregulin production in colon subepithelialmyofibroblasts, activatingerk1-2 signaling in synergy with EGRF. Cancer Lett. 2013;328:73\u201382.","journal-title":"Cancer Lett"},{"key":"139_CR17","first-page":"1213","volume":"10","author":"M Cotterchio","year":"2001","unstructured":"Cotterchio M, Krieger N, Sloan M, Steinegart A. Non-steroidal anti-inflammatory drug use and breast cancer risk. Cancer Epidemiol Biomarkers Prev. 2001;10:1213\u20137.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"139_CR18","doi-asserted-by":"publisher","first-page":"4798","DOI":"10.1038\/sj.onc.1209608","volume":"25","author":"S Fulda","year":"2006","unstructured":"Fulda S, Debatin KM. Extrinsic versus intrinsic apoptosis pathways in anticancer chemotherapy. Oncogene. 2006;25:4798\u2013811.","journal-title":"Oncogene"},{"key":"139_CR19","doi-asserted-by":"publisher","first-page":"15294","DOI":"10.1073\/pnas.261560998","volume":"98","author":"A Almeida","year":"2001","unstructured":"Almeida A, Almeida J, Bolanos JP, Moncada S. Different responses of astrocytes and neurons to nitric oxide: the role of glycolytically generated ATP in astrocyte protection. Proc Natl Acad Sci U S A. 2001;98:15294\u20139.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"139_CR20","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1007\/s00280-003-0591-2","volume":"1","author":"N Fujita","year":"2003","unstructured":"Fujita N, Tsuruo T. Survival-signaling pathway as a promising target for cancer chemotherapy. Cancer Chemother Pharmacol. 2003;1:24\u20138.","journal-title":"Cancer Chemother Pharmacol"},{"key":"139_CR21","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.bcp.2010.09.002","volume":"81","author":"J Rudner","year":"2011","unstructured":"Rudner J, Elsaesser SJ, Jendrossek V, Huber SM. Anti-apoptotic Bcl-2 fails to form efficient complexes with pro-apoptotic Bak to protect from celecoxib-induced apoptosis. Biochem Pharmacol. 2011;81:32\u201342.","journal-title":"Biochem Pharmacol"},{"key":"139_CR22","first-page":"915","volume":"25","author":"BK Choi","year":"2004","unstructured":"Choi BK, Choi CH, Oh HL, Kim YK. Role of ERK activation in cisplatin-induced apoptosis in A172 human glioma cells. Neuro Toxicology. 2004;25:915\u201324.","journal-title":"Neuro Toxicology"},{"key":"139_CR23","doi-asserted-by":"publisher","first-page":"6570","DOI":"10.1038\/sj.onc.1204815","volume":"20","author":"Y Liang","year":"2001","unstructured":"Liang Y, Yan C, Schor NF. Apoptosis in the absence of caspase 3. Oncogene. 2001;20:6570\u20138.","journal-title":"Oncogene"},{"key":"139_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4172\/1948-593X.1000036","volume":"3","author":"AB Shirode","year":"2011","unstructured":"Shirode AB, Sylvester PW. Mechanisms mediating the synergistic anticancer effects of combined \u03b3-tocotrienol and celecoxib treatment. J Bioanal Biomed. 2011;3:1\u20137.","journal-title":"J Bioanal Biomed"},{"key":"139_CR25","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.3390\/ph5121346","volume":"5","author":"M Dovizio","year":"2012","unstructured":"Dovizio M, Tacconelli S, Sostresm C, Ricciotti E, Patrignani P. Mechanistic and pharmacological issues of aspirin as an anticancer agent. Pharmaceuticals. 2012;5:1346\u201371.","journal-title":"Pharmaceuticals"},{"key":"139_CR26","doi-asserted-by":"publisher","first-page":"6910","DOI":"10.1038\/sj.onc.1203238","volume":"18","author":"M Barkett","year":"1999","unstructured":"Barkett M, Gilmore TD. Control of apoptosis by Rel\/NF-kappaB transcription factors. Oncogene. 1999;18:6910\u201324.","journal-title":"Oncogene"},{"key":"139_CR27","doi-asserted-by":"publisher","first-page":"4880","DOI":"10.1182\/blood-2007-10-117994","volume":"111","author":"B Sung","year":"2008","unstructured":"Sung B, Pandey MK, Ahn KS, Yi T, Chaturvedi MM, Liu M, et al. Anacardic acid (6-nonadecyl salicylic acid), an inhibitor of histone acetyltransferase, suppresses expression of nuclear factor-kappa B regulated gene products involved in cell survival, proliferation, invasion, and inflammation through inhibition of the inhibitory subunit of nuclear factor-kappaBalph kinase, leading to potentiation of apoptosis. Blood. 2008;111:4880\u201391.","journal-title":"Blood"},{"key":"139_CR28","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/1756-9966-27-53","volume":"27","author":"I Meteoglu","year":"2008","unstructured":"Meteoglu I, Erdogdu IH, Meydan N, Erkus M, Barutca S. NF-KAPPAb expression correlates with apoptosis and angiogenesis in clear cell renal cell carcinoma tissues. J Exp Clin Cancer Res. 2008;27:53\u201361.","journal-title":"J Exp Clin Cancer Res"},{"key":"139_CR29","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/j.cell.2004.10.017","volume":"119","author":"CG Pham","year":"2004","unstructured":"Pham CG, Bubici C, Zazzeroni F, Papa S, Jones J, Alvarez K, et al. Ferritin heavy chain upregulation by NFkappa inhibits TNFalpha-induced apoptosis by suppressing reactive oxygen species. Cell. 2004;119:529\u201342.","journal-title":"Cell"},{"key":"139_CR30","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.1039\/c0mb00201a","volume":"7","author":"F Rezaie","year":"2011","unstructured":"Rezaie F, Salimi M, Ghahremani MH, Vaziri B. Potential molecular targets in chemopreventative action of celecoxib: a proteomics analysis of J774.A1 macrophage-like cell line. Mol BioSyst. 2011;7:1306\u201311.","journal-title":"Mol BioSyst"},{"key":"139_CR31","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.biocel.2010.09.011","volume":"43","author":"SV Bava","year":"2001","unstructured":"Bava SV, Sreekanth CN, Thulasidasan AK, Anto NP, Cheriyan VT, Puliyappadamba VT, et al. Akt is upstream and MAPKs are downstream of NF-\u03baB in paclitaxel-induced survival signaling events, which are down-regulated by curcumin contributing to their synergism. Int J Biochem Cell Biol. 2001;43:331\u201341.","journal-title":"Int J Biochem Cell Biol"},{"key":"139_CR32","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1124\/jpet.106.107367","volume":"319","author":"S Zhuang","year":"2006","unstructured":"Zhuang S, Schnellmann RG. A death-promoting role for extracellular signal-regulated kinase. J Pharmacol Exp Ther. 2006;319:991\u20137.","journal-title":"J Pharmacol Exp Ther"},{"key":"139_CR33","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.taap.2008.12.005","volume":"235","author":"Q Li","year":"2009","unstructured":"Li Q, Suen TC, Sun H, Arita A, Costa M. Nickel compounds induce apoptosis in human bronchial epithelial Beas-2B cells by activation of c-Myc through ERK pathway. Toxicol Appl Pharmacol. 2009;235:191\u20138.","journal-title":"Toxicol Appl Pharmacol"},{"key":"139_CR34","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1038\/sj.bjc.6690062","volume":"79","author":"GH Zhu","year":"1998","unstructured":"Zhu GH, Wong BC, Eggo MC, Ching CK, Yuen ST, Chan EY, et al. Non-steroidal anti-inflammatory drug-induced apoptosis in gastric cancer cells is blocked by protein kinase C activation through inhibition of c-myc. Br J Cancer. 1998;79:393\u2013400.","journal-title":"Br J Cancer"},{"key":"139_CR35","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1007\/s005350200019","volume":"37","author":"Y Kishimoto","year":"2002","unstructured":"Kishimoto Y, Yashima K, Morisawa T, Shiota G, Kawasaki H, Hasegawa J. Effects of cyclooxygenase-2 inhibitor NS-398 on APC and c-myc expression in rat colon carcinogenesis induced by azoxymethane. J Gastroenterol. 2002;37:186\u201393.","journal-title":"J Gastroenterol"},{"key":"139_CR36","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1038\/sj.bjc.6600815","volume":"88","author":"J Ostrowski","year":"2003","unstructured":"Ostrowski J, Wocial T, Skurzak H, Bartnik W. Do altering in ornithine decarboxylase activity and gene expression contribute to antiproliferative properties of COX inhibitors? Br J Cancer. 2003;88:1143\u201351.","journal-title":"Br J Cancer"},{"key":"139_CR37","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1073\/pnas.1008848108","volume":"108","author":"DN Boone","year":"2011","unstructured":"Boone DN, Ying Q, Li Z, Hann SR. Egr1 mediates p53-independent c-Myc\u2013induced apoptosis via a noncanonical ARF-dependent transcriptional mechanism. Proc Natl Acad Sci U S A. 2011;108:632\u20137.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"139_CR38","first-page":"377","volume":"4","author":"J Liu","year":"2007","unstructured":"Liu J, Liu YG, Huang R, Yao C, Li S, Yang W, et al. Concurrent down-regulation of Egr-1 and gelsolin in the majority of human breast cancer cells. Cancer Genomics Proteomics. 2007;4:377\u201386.","journal-title":"Cancer Genomics Proteomics"},{"key":"139_CR39","doi-asserted-by":"publisher","first-page":"3739","DOI":"10.1158\/1535-7163.MCT-08-0548","volume":"7","author":"SH Lee","year":"2008","unstructured":"Lee SH, Bahn JH, Choi CK, Whitlock NC, English AE, Safe S, et al. ESE-1\/EGR-1 Pathway Plays a Role in Tolfenamic Acid-induced Apoptosis in Colorectal Cancer Cells. Mol Cancer Ther. 2008;7:3739\u201350.","journal-title":"Mol Cancer Ther"},{"key":"139_CR40","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1002\/jcb.24944","volume":"116","author":"M Norouzi","year":"2015","unstructured":"Norouzi M, Norouzi SH, Amini M, Amanzadeh A, Irian S, Salimi M. Apoptotic effects of two COX-2 inhibitors on breast adenocarcinoma cells through COX-2 independent Pathway. J Cell Biochem. 2015;116:81\u201390.","journal-title":"J Cell Biochem"}],"container-title":["DARU Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s40199-015-0139-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s40199-015-0139-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s40199-015-0139-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s40199-015-0139-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,16]],"date-time":"2019-09-16T16:51:51Z","timestamp":1568652711000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1186\/s40199-015-0139-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1,7]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["139"],"URL":"https:\/\/doi.org\/10.1186\/s40199-015-0139-0","relation":{},"ISSN":["2008-2231"],"issn-type":[{"value":"2008-2231","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,1,7]]},"assertion":[{"value":"3 August 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 December 2015","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 January 2016","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"1"}}